Ä¢¹½AV

Novo Nordisk inks licensing agreement for oral weight loss drug candidate: Novo wants to find out if patients could benefit from a weight loss drug pill after they use one of its blockbuster GLP-1s.

Consumers are turning to digital channels for medical information and advice and to research healthcare products, treatments, and services. Here’s what healthcare and pharma marketers need to know about converting information-seeking consumers into customers.

Nearly five years since hundreds of Chinese apps were banned from India’s app stores, some can be found in the country’s Apple Store and Google Play once again. Will this open the door for other previously banned Chinese apps?

Tesla’s at the center of a heated political battle, and insurers and their customers are paying the price.